Properties
Description
Remogliflozin is a sodium-glucose cotransporter inhibitor, preventing the kidneys from reabsorbing glucose.
Molecular Formula
C23H34N2O7
Identity
Confirmed by NMR/HPLC/MS.
Applications
Remogliflozin is an SGLT inhibitor relevant in diabetes research for its role in glucose homeostasis.